Skip to main content
Erschienen in: Irish Journal of Medical Science (1971 -) 1/2022

08.03.2021 | Original Article

The correlation between 6-min walk test and respiratory parameters in children with cystic fibrosis

verfasst von: Zahra Roshanzamir, Rohola Shirzadi, Mohammadreza Modaresi

Erschienen in: Irish Journal of Medical Science (1971 -) | Ausgabe 1/2022

Einloggen, um Zugang zu erhalten

Abstract

Background

The 6-min walk test (6MWT) is a sub-maximal exercise test and has been widely used for evaluating of exercise capacity of patients with cystic fibrosis (CF) in recent years. Few studies have examined the relationship between 6MWT and parameters used to assess the severity of the disease in children with CF. In this study, we have examined this relationship to find out if 6MWT can be a marker of the severity of cystic fibrosis.

Methods

A cross-sectional study was done to analyze the correlations among spirometry parameters, body mass index (BMI), chest tomography (CT), and 6MWT. CF patients, aged 7–14 years, were involved.

Results

Seventy-six patients, 32F/44M, mean age 10.49 ± 3.18 years, were studied. The mean distance in 6MWT was 447 ± 84.1. The following correlations versus distance were found: FEV1 (r = 0.255, p = 0.026), FVC(r = 0.285, p = 0.013), FEF25–75% (r = 0.546, p < 0.001), BMI (r = 0.163, p = 0.160), and CT (r = 0.075, p = 0.520).The following correlations versus O2 saturation (SpO2) decline were found: FEV1 (r = −0.393, p < 0.001), FVC (r = −0.431, p < 0.001), FEF25–75% (r = −0.296, p = 0.010), BMI (r = 0.042, p = 0.721), and CT (r = −0.196, p = 0.090). There was a significant correlation between 6MWT (distance and SpO2 decline) and pulmonary function test. There was no significant correlation between BMI, chest CT, and 6MWT.

Conclusions

6MWT can be applied beside spirometry and chest CT for CF patients follow up.
Literatur
1.
Zurück zum Zitat Reis FJ, Damaceno N (1998) Fibrose cística. J Pediatr (Rio J) 74(Supl 1):S76-S94 Reis FJ, Damaceno N (1998) Fibrose cística. J Pediatr (Rio J) 74(Supl 1):S76-S94
2.
Zurück zum Zitat Mandrusiak A, Maurer C, MacDonald J et al (2009) Functional capacity tests in young people with cystic fibrosis. N Z J Physiother. 37(1):13–16 Mandrusiak A, Maurer C, MacDonald J et al (2009) Functional capacity tests in young people with cystic fibrosis. N Z J Physiother. 37(1):13–16
3.
Zurück zum Zitat Williams MT (1994) Chest physiotherapy and cystic fibrosis: why is the most effective form of treatment still unclear? Chest 106(6):1872–1883CrossRef Williams MT (1994) Chest physiotherapy and cystic fibrosis: why is the most effective form of treatment still unclear? Chest 106(6):1872–1883CrossRef
4.
Zurück zum Zitat Moorcroft A, Dodd M, Webb A (1997) Exercise testing and prognosis in adult cystic fibrosis. Thorax 52(3):291–293CrossRef Moorcroft A, Dodd M, Webb A (1997) Exercise testing and prognosis in adult cystic fibrosis. Thorax 52(3):291–293CrossRef
5.
Zurück zum Zitat Holland AE, Denehy L, Ntoumenopoulos G et al (2003) Non-invasive ventilation assists chest physiotherapy in adults with acute exacerbations of cystic fibrosis. Thorax 58(10):880–884CrossRef Holland AE, Denehy L, Ntoumenopoulos G et al (2003) Non-invasive ventilation assists chest physiotherapy in adults with acute exacerbations of cystic fibrosis. Thorax 58(10):880–884CrossRef
6.
Zurück zum Zitat Radtke T, Faro A, Wong J et al (2011) Exercise testing in pediatric lung transplant candidates with cystic fibrosis. Pediatr Transplant 15(3):294–299CrossRef Radtke T, Faro A, Wong J et al (2011) Exercise testing in pediatric lung transplant candidates with cystic fibrosis. Pediatr Transplant 15(3):294–299CrossRef
7.
Zurück zum Zitat Enright PL, McBurnie MA, Bittner V et al (2003) The 6-min walk test: a quick measure of functional status in elderly adults. Chest 123(2):387–398CrossRef Enright PL, McBurnie MA, Bittner V et al (2003) The 6-min walk test: a quick measure of functional status in elderly adults. Chest 123(2):387–398CrossRef
8.
Zurück zum Zitat Laboratories ACoPSfCPF (2002) ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 166:111–7 Laboratories ACoPSfCPF (2002) ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 166:111–7
9.
Zurück zum Zitat Barry SC, Gallagher CG (2007) The repeatability of submaximal endurance exercise testing in cystic fibrosis. Pediatr Pulmonol 42(1):75–82CrossRef Barry SC, Gallagher CG (2007) The repeatability of submaximal endurance exercise testing in cystic fibrosis. Pediatr Pulmonol 42(1):75–82CrossRef
10.
Zurück zum Zitat Gulmans V, Van Veldhoven N, De Meer K, Helders P (1996) The six-minute walking test in children with cystic fibrosis: reliability and validity. Pediatr Pulmonol 22(2):85–89CrossRef Gulmans V, Van Veldhoven N, De Meer K, Helders P (1996) The six-minute walking test in children with cystic fibrosis: reliability and validity. Pediatr Pulmonol 22(2):85–89CrossRef
11.
Zurück zum Zitat Chetta A, Pisi G, Zanini A et al (2001) Six-minute walking test in cystic fibrosis adults with mild to moderate lung disease: comparison to healthy subjects. Respir Med 95(12):986–991CrossRef Chetta A, Pisi G, Zanini A et al (2001) Six-minute walking test in cystic fibrosis adults with mild to moderate lung disease: comparison to healthy subjects. Respir Med 95(12):986–991CrossRef
12.
Zurück zum Zitat de Agüero Barrio MG, García GH, Gartner S (2009) Protocol for the diagnosis and follow up of patients with cystic fibrosis. Anales de pediatria (Barcelona, Spain: 2003) p. 250–64 de Agüero Barrio MG, García GH, Gartner S (2009) Protocol for the diagnosis and follow up of patients with cystic fibrosis. Anales de pediatria (Barcelona, Spain: 2003) p. 250–64
13.
Zurück zum Zitat Tiddens HA, Stick SM, Davis S (2014) Multi-modality monitoring of cystic fibrosis lung disease: the role of chest computed tomography. Paediatr Respir Rev 15(1):92–97PubMed Tiddens HA, Stick SM, Davis S (2014) Multi-modality monitoring of cystic fibrosis lung disease: the role of chest computed tomography. Paediatr Respir Rev 15(1):92–97PubMed
14.
Zurück zum Zitat Taylor-Robinson D, Whitehead M, Diderichsen F et al (2012) Understanding the natural progression in% FEV1 decline in patients with cystic fibrosis: a longitudinal study. Thorax 67(10):860–866CrossRef Taylor-Robinson D, Whitehead M, Diderichsen F et al (2012) Understanding the natural progression in% FEV1 decline in patients with cystic fibrosis: a longitudinal study. Thorax 67(10):860–866CrossRef
15.
Zurück zum Zitat Guillén MJ, Posadas AS, Asensi JV et al (1999) Reproductibilidad del test de la marcha (walking test) en pacientesafectos de fibrosis quística. An Esp Pediatr 51(5):475–478 Guillén MJ, Posadas AS, Asensi JV et al (1999) Reproductibilidad del test de la marcha (walking test) en pacientesafectos de fibrosis quística. An Esp Pediatr 51(5):475–478
16.
Zurück zum Zitat Farrell PM, Rosenstein BJ, White TB et al (2008) Guidelines for diagnosis of cystic fibrosis in newborns through older adults: Cystic Fibrosis Foundation consensus report. J Pediatr 153(2):S4–S14CrossRef Farrell PM, Rosenstein BJ, White TB et al (2008) Guidelines for diagnosis of cystic fibrosis in newborns through older adults: Cystic Fibrosis Foundation consensus report. J Pediatr 153(2):S4–S14CrossRef
17.
Zurück zum Zitat Miller MR, Hankinson J, Brusasco V et al (2005) Standardisation of spirometry. Eur Respir J 26(2):319–338CrossRef Miller MR, Hankinson J, Brusasco V et al (2005) Standardisation of spirometry. Eur Respir J 26(2):319–338CrossRef
18.
Zurück zum Zitat Graham BL, Steenbruggen I, Miller MR et al (2019) Standardization of spirometry 2019 update. An official American thoracic society and European respiratory society technical statement. Am J Respir Crit Care Med 200(8):e70-e88. Graham BL, Steenbruggen I, Miller MR et al (2019) Standardization of spirometry 2019 update. An official American thoracic society and European respiratory society technical statement. Am J Respir Crit Care Med 200(8):e70-e88.
19.
Zurück zum Zitat Polgar G, Varuni P (1971) Pulmonary function testing in children: techniques and standards: Saunders Limited Polgar G, Varuni P (1971) Pulmonary function testing in children: techniques and standards: Saunders Limited
20.
Zurück zum Zitat Bhalla M, Turcios N, Aponte V et al (1991) Cystic fibrosis: scoring system with thin-section CT. Radiology 179(3):783–788CrossRef Bhalla M, Turcios N, Aponte V et al (1991) Cystic fibrosis: scoring system with thin-section CT. Radiology 179(3):783–788CrossRef
21.
Zurück zum Zitat Ziegler B, Rovedder PME, Lukrafka JL et al (2007) Capacidade submáxima de exercício em pacientes adolescentes e adultos com fibrose cística. J Bras Pneumol 33(3):263–9 Ziegler B, Rovedder PME, Lukrafka JL et al (2007) Capacidade submáxima de exercício em pacientes adolescentes e adultos com fibrose cística. J Bras Pneumol 33(3):263–9
22.
Zurück zum Zitat Cunha MT, Rozov T, de Oliveira RC, Jardim JR (2006) Six-minute walk test in children and adolescents with cystic fibrosis. Pediatr Pulmonol 41(7):618–622CrossRef Cunha MT, Rozov T, de Oliveira RC, Jardim JR (2006) Six-minute walk test in children and adolescents with cystic fibrosis. Pediatr Pulmonol 41(7):618–622CrossRef
23.
Zurück zum Zitat Stollar F, Rodrigues JC, Cunha MT et al (2012) Six minute walk test Z score: correlations with cystic fibrosis severity markers. J Cyst Fibros 11(3):253–256CrossRef Stollar F, Rodrigues JC, Cunha MT et al (2012) Six minute walk test Z score: correlations with cystic fibrosis severity markers. J Cyst Fibros 11(3):253–256CrossRef
24.
Zurück zum Zitat Pellegrino R, Viegi G, Brusasco V et al (2005) Interpretative strategies for lung function tests. Eur Respir J 26(5):948–968CrossRef Pellegrino R, Viegi G, Brusasco V et al (2005) Interpretative strategies for lung function tests. Eur Respir J 26(5):948–968CrossRef
Metadaten
Titel
The correlation between 6-min walk test and respiratory parameters in children with cystic fibrosis
verfasst von
Zahra Roshanzamir
Rohola Shirzadi
Mohammadreza Modaresi
Publikationsdatum
08.03.2021
Verlag
Springer International Publishing
Erschienen in
Irish Journal of Medical Science (1971 -) / Ausgabe 1/2022
Print ISSN: 0021-1265
Elektronische ISSN: 1863-4362
DOI
https://doi.org/10.1007/s11845-021-02564-9

Weitere Artikel der Ausgabe 1/2022

Irish Journal of Medical Science (1971 -) 1/2022 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

ADT zur Radiatio nach Prostatektomie: Wenn, dann wohl länger

24.05.2024 Prostatakarzinom Nachrichten

Welchen Nutzen es trägt, wenn die Strahlentherapie nach radikaler Prostatektomie um eine Androgendeprivation ergänzt wird, hat die RADICALS-HD-Studie untersucht. Nun liegen die Ergebnisse vor. Sie sprechen für länger dauernden Hormonentzug.

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

22.05.2024 Melanom Nachrichten

Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.